First Horizon Advisors’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-157
| Closed | -$9K | – | 1642 |
|
|
2019
Q3 | $9K | Hold |
157
| – | – | ﹤0.01% | 1119 |
|
|
2019
Q2 | $8K | Hold |
157
| – | – | ﹤0.01% | 1173 |
|
|
2019
Q1 | $10K | Buy |
+157
| New | +$11.6K | ﹤0.01% | 1063 |
|
|
2018
Q1 | – | Sell |
-890
| Closed | -$31K | – | 1495 |
|
|
2017
Q4 | $31K | Hold |
890
| – | – | ﹤0.01% | 676 |
|
|
2017
Q3 | $28K | Hold |
890
| – | – | ﹤0.01% | 674 |
|
|
2017
Q2 | $27K | Hold |
890
| – | – | ﹤0.01% | 674 |
|
|
2017
Q1 | $29K | Sell |
890
-177
| -17% | -$5.24K | ﹤0.01% | 698 |
|
|
2016
Q4 | $31K | Hold |
1,067
| – | – | ﹤0.01% | 671 |
|
|
2016
Q3 | $31K | Hold |
1,067
| – | – | ﹤0.01% | 665 |
|
|
2016
Q2 | $27K | Hold |
1,067
| – | – | ﹤0.01% | 682 |
|
|
2016
Q1 | $28K | Buy |
1,067
+334
| +46% | +$9.17K | ﹤0.01% | 703 |
|
|
2015
Q4 | $25K | Sell |
733
-491
| -40% | -$13.2K | ﹤0.01% | 669 |
|
|
2015
Q3 | $25K | Buy |
1,224
+27
| +2% | +$696 | ﹤0.01% | 728 |
|
|
2015
Q2 | $33K | Buy |
1,197
+395
| +49% | +$11.1K | ﹤0.01% | 671 |
|
|
2015
Q1 | $24K | Hold |
802
| – | – | ﹤0.01% | 788 |
|
|
2014
Q4 | $25K | Hold |
802
| – | – | ﹤0.01% | 770 |
|
|
2014
Q3 | $22K | Hold |
802
| – | – | ﹤0.01% | 798 |
|
|
2014
Q2 | $20K | Buy |
+802
| New | +$21.3K | ﹤0.01% | 831 |
|
|
2013
Q4 | – | Sell |
-385
| Closed | -$12K | – | 1444 |
|
|
2013
Q3 | $12K | Hold |
385
| – | – | ﹤0.01% | 798 |
|
|
2013
Q2 | $12K | Buy |
+385
| New | +$12.6K | 0.01% | 485 |
|
First Horizon Advisors's GHDX Position: Q4 2019 in Review
First Horizon Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 157 shares — an estimated $9K sold.
First Horizon Advisors first reported a position in GHDX in Q2 2013 and held it in 20 quarters. The position peaked at $33K in Q2 2015. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- First Horizon Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- First Horizon Advisors sold 157 Genomic Health, Inc. shares in Q4 2019, an estimated $9K.
- First Horizon Advisors first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 20 quarters.
- First Horizon Advisors's Genomic Health, Inc. position peaked at $33K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on First Horizon Advisors's 13F filing for Q4 2019, filed 7 Jan 2020.